What one share of Dare Bioscience holds
The terms “we,” “us,” “our,” “Daré” or the “Company” refer collectively to Daré Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or the context otherwise requires. Unless otherwise stated, references to particular years, quarters, months or periods refer to our fiscal years ending December 31 and the associated quarters, months and periods of those fiscal years.
Dare Bioscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.10 |
|---|---|
| Profit | −$0.78 |
| Capex (buildings and equipment) | $0.03 |
| Free cash flow | −$0.83 |
| Cash and investments | $0.83 |
| Book value | −$0.04 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$9.67 | $7.69 | −$13.04 | — | −$9.37 |
| 2018 | — | −$18.72 | $0.01 | −$11.49 | — | $7.07 |
| 2019 | — | −$11.60 | $0.00 | −$10.26 | — | $0.27 |
| 2020 | — | −$10.93 | $0.01 | −$10.07 | — | −$0.33 |
| 2021 | — | −$7.59 | $0.00 | −$5.65 | — | $5.54 |
| 2022 | — | −$4.39 | $0.01 | −$2.58 | — | $1.57 |
| 2023 | — | −$4.15 | $0.09 | −$5.43 | — | −$0.61 |
| 2024 | $0.00 | −$0.48 | $0.07 | $0.58 | — | −$0.69 |
| 2025 | $0.09 | −$1.20 | $0.03 | −$0.92 | — | $0.20 |
Common questions about Dare Bioscience
How much does one share of Dare Bioscience earn?
Over the last 12 months, Dare Bioscience lost $0.78 for each share on $0.10 of sales.
Does Dare Bioscience pay a dividend?
Dare Bioscience didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Dare Bioscience’s book value per share?
Dare Bioscience’s book value is negative (−$0.04 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Dare Bioscience have?
Each share of Dare Bioscience has $0.83 of cash and investments, as of June 30, 2026.
What is Dare Bioscience’s free cash flow per share?
−$0.83 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Dare Bioscience bought back shares?
Dare Bioscience’s share count rose about 15965% from 2016 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.